BioNTech CEO Prof. Dr. Uğur Şahin – erwartet dass der bestehende Covid-19 Impfstoff auch bei der neuen Omikron Variante vor schweren Krankheitsverläufen schützen kann

This entry was posted on Mittwoch, Dezember 1st, 2021 at 10:19 and is filed under Administration, Healthcare Info. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Leave a Reply

You must be logged in to post a comment.